Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Beyondspring Inc BYSI

Healthcare Biotechnology
BeyondSpring Inc. is a clinical-stage global biopharmaceutical company. The Company is focused on developing innovative therapies to improve clinical outcomes for patients with high unmet medical needs. The Company operates through two segments: the Plinabulin pipeline and Targeted Protein Degradation (TPD) platform. Plinabulin is being developed as a pipeline in a drug in various cancer... see more

Recent & Breaking News (NDAQ:BYSI)

BeyondSpring and Leading Cancer Center to Present Poster at SITC's 38th Annual Meeting

GlobeNewswire September 27, 2023

BeyondSpring to Participate in the R.W. Baird's 2023 Global Healthcare Conference

GlobeNewswire September 7, 2023

SEED Therapeutics, BeyondSpring Subsidiary, Appoints Jackson Tai to Board of Directors

GlobeNewswire June 20, 2023

BeyondSpring and Leading Cancer Center Present Poster Highlighting Plinabulin's Ability to Reduce Infectious Neutropenic Fever for Multiple Myeloma Patients Undergoing AHCT

GlobeNewswire June 7, 2023

BeyondSpring and Leading Cancer Center to Present Poster at 2023 ASCO Annual Meeting

GlobeNewswire May 18, 2023

BeyondSpring Provides Business Update and Reports Year End 2022 Financial Results

GlobeNewswire April 18, 2023

BeyondSpring Files 2022 Annual Report on Form 20-F

GlobeNewswire April 18, 2023

BeyondSpring Enrolls First Patient in Phase 2 Study with Plinabulin, Keytruda and Docetaxel in Patients with Metastatic Non-Small Cell Lung Cancer Who Progressed After Immunotherapy

GlobeNewswire March 1, 2023

BeyondSpring Receives Notifications from Nasdaq Regarding Compliance With Listing Rules

GlobeNewswire January 9, 2023

BeyondSpring Presents Positive Data with Plinabulin for the Prevention of Docetaxel-Induced Neutropenia in Patients with Non-Small Cell Lung Cancer and Breast Cancer at Three Medical Conferences

GlobeNewswire December 13, 2022

BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements

GlobeNewswire November 23, 2022

BeyondSpring Presents New Clinical Evidence of Plinabulin Protection of Granulocyte-Monocyte Progenitor Stem Cells for the Prevention of Chemotherapy-Induced Neutropenia at the ESMO Congress 2022

GlobeNewswire September 13, 2022

BeyondSpring Presents New Data for the Use of Plinabulin and Pegfilgrastim to Decrease Neutropenia Burden in Peri-Transplant Multiple Myeloma Patients at the 19th International Myeloma Society Annual Meeting

GlobeNewswire August 29, 2022

BeyondSpring Presents New Clinical Data in the Chemotherapy-Induced Neutropenia and NSCLC Programs at the 2022 ASCO Annual Meeting

GlobeNewswire May 27, 2022

BeyondSpring Announces Three Poster Presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire April 28, 2022

BeyondSpring Files 2021 Annual Report on Form 20-F

GlobeNewswire April 14, 2022

BeyondSpring Announces Fourth Quarter and Year End 2021 Financial Results and Provides a Corporate Update

GlobeNewswire April 14, 2022

BeyondSpring to Announce Fourth Quarter and Year End 2021 Financial Results and Host a Conference Call on Thursday, April 14, 2022

GlobeNewswire April 8, 2022

BeyondSpring Announces Organizational Streamlining

GlobeNewswire January 11, 2022

BeyondSpring Announces Third Quarter 2021 Financial Results and Provides a Corporate Update

GlobeNewswire December 30, 2021